Listed

ENDRA Life Sciences Inc.: Form 10-Q for the period ended Jun 30, 2018

Filed with the SEC on Aug 13, 2018 and accepted by EDGAR at Aug 13, 2018, 16:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-04-01 to 2018-06-30$0us-gaap:Revenues
Revenue6 months2018-01-01 to 2018-06-30$6.2kus-gaap:Revenues
Cost of revenue3 months2018-04-01 to 2018-06-30$0us-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2018-01-01 to 2018-06-30$0us-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2018-04-01 to 2018-06-30$0us-gaap:GrossProfit
Gross profit6 months2018-01-01 to 2018-06-30$6.2kus-gaap:GrossProfit
Research and development3 months2018-04-01 to 2018-06-30$839.8kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-01-01 to 2018-06-30$2.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2018-04-01 to 2018-06-30−$1.8mus-gaap:OperatingIncomeLoss
Operating income6 months2018-01-01 to 2018-06-30−$4.7mus-gaap:OperatingIncomeLoss
Income tax3 months2018-04-01 to 2018-06-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax6 months2018-01-01 to 2018-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-04-01 to 2018-06-30−$1.8mus-gaap:NetIncomeLoss
Net income6 months2018-01-01 to 2018-06-30−$4.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-04-01 to 2018-06-30−$0.47us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2018-01-01 to 2018-06-30−$1.19us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2018-01-01 to 2018-06-30−$4.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2018-01-01 to 2018-06-30$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-06-30$2.2mus-gaap:Cash
Current assetsAt period end2018-06-30$2.8mus-gaap:AssetsCurrent
Total assetsAt period end2018-06-30$3.0mus-gaap:Assets
Current liabilitiesAt period end2018-06-30$751.4kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-06-30$1.1mus-gaap:Liabilities
Shareholders' equityAt period end2018-06-30$1.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001654954-18-008949. Last ingested by Listed: Nov 10, 2026, 17:03 ET. Listed shows no prices and gives no investment advice.